Lipid-regulating drugs can not only regulate lipid levels

but also has the effects of antioxidant

antiinflammatory

anti-stress and thrombosis inhibition

stabilize or shrink atherosclerotic plaques

reduce the occurrence of stroke and cardiovascular events

which become an important measure for primary and secondary prevention. This article summarizes the progress of lipid-regulating drugs

especially proprotein convertase subtilisin/kexin type 9 inhibitors

and the key points of pharmacological monitoring in treatment.